Breast cancer diagnostics sales will expand through 2036, with imaging holding 52% of the type outlook segment in 2026. The market was valued at USD 6.52 billion in 2025 and is expected to be worth USD 14.87 billion by 2036, creating an incremental opportunity of USD 10.18 billion.